Synergistic inhibition of platelet aggregation by forskolin plus PGE1 or 2-fluoroadenosine: effects of 2',5'-dideoxyadenosine and 5'-methylthioadenosine.
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000527:Alprostadil; D005576:Colforsin; D003839:Deoxyadenosines / Q000031:analogs & derivatives* / Q000494:pharmacology; D016048:Dideoxyadenosine / Q000031:analogs & derivatives*; D004224:Diterpenes / Q000494:pharmacology*; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects*; D011458:Prostaglandins E / Q000494:pharmacology*; D013872:Thionucleosides / Q000494:pharmacology*
D000067956:Adenylyl Cyclase Inhibitors; D003839:Deoxyadenosines; D004224:Diterpenes; D011458:Prostaglandins E; D013872:Thionucleosides; C034064:2-fluoroadenosine; D005576:Colforsin; D016048:Dideoxyadenosine; C008500:5'-methylthioadenosine; C021008:2',5'-dideoxyadenosine; D000527:Alprostadil; D000241:Adenosine